Study title: A randomized, multi-center, single-blind, placebo-controlled cross-over study planned to assess the efficacy in the early part of the school day of two methylphenidate delivery system, Ritalin LA® 20 mg versus Concerta 18 and 36 mg.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Mental Disorders | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: METHYLPHENIDATE | |||||
ATC code: | |||||
Document link: Ritalin-EMA spreadsheet_CRIT124DUS07.xls | |||||
Document date: 2011-09-27 | |||||
Study number: RIT124D US07 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |